Privia Health to Enter Washington State
ARLINGTON, Va., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) a national physician enablement company, announced...
ARLINGTON, Va., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) a national physician enablement company, announced...
Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE:...
Live webcast fireside chat on Monday, August 7th at 1:00 PM ETISELIN, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Outlook...
Record second quarter 2023 Net Revenue of $72.1 million, up 12.7% year-over-year and 3.9% sequentially, representing the 7th consecutive quarter...
-A Phase 2a study of BAER-101 in epilepsy is planned to initiate in 2024MIAMI, Aug. 01, 2023 (GLOBE NEWSWIRE) --...
David Long served on GBB Drink Lab’s Advisory Board, guiding the development and marketing of the world’s first rapid alcohol...
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PTBURLINGAME, Calif., Aug. 01, 2023 (GLOBE...
Renowned Jamaican Psilocybin Cultivator and Supplier Expands Operations and Sets Eyes on U.S.RUNAWAY BAY, Jamaica, Aug. 01, 2023 (GLOBE NEWSWIRE)...
Sale Completes Awakn's Exit From Healthcare Services To Focus Solely on Biotechnology Research and DevelopmentToronto, Ontario--(Newsfile Corp. - August 1,...
VANCOUVER BC / ACCESSWIRE / August 1, 2023 / EMPOWER CLINICS INC. (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company") announces today,...
This announcement contains inside informationStrategic Divestment of C4XD's Orexin-1 Receptor Antagonist Programme to Indivior for £15.95 MillionSale encompasses all rights...